LADENBURG THALMANN FINANCIAL SERVICES INC. - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 211 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$16,000
+433.3%
1,300
+584.2%
0.00%
Q3 2019$3,000
-25.0%
190
-42.9%
0.00%
Q2 2019$4,0000.0%3330.0%0.00%
Q1 2019$4,000
-89.2%
333
-87.6%
0.00%
Q4 2018$37,000
+27.6%
2,694
+26.8%
0.00%
Q3 2018$29,000
-37.0%
2,125
-24.9%
0.00%
Q2 2018$46,0000.0%2,8300.0%0.00%
Q1 2018$46,000
+64.3%
2,830
+83.6%
0.00%
Q4 2017$28,000
+75.0%
1,541
+86.1%
0.00%
Q3 2017$16,000
+700.0%
828
+342.8%
0.00%
Q2 2017$2,000
-77.8%
187
-76.2%
0.00%
Q1 2017$9,000
-30.8%
787
-55.0%
0.00%
Q4 2016$13,0001,7500.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,609,429$55,961,0003.12%
INVESTOR AB 1,835,974$11,934,0000.86%
GLOBEFLEX CAPITAL L P 244,183$1,587,0000.40%
Campbell & CO Investment Adviser LLC 21,446$139,0000.37%
Birchview Capital, LP 80,000$520,0000.30%
FEDERATED HERMES, INC. 13,879,968$90,220,0000.26%
MENTA CAPITAL LLC 388,582$2,526,0000.24%
Sitrin Capital Management LLC 40,000$260,0000.20%
ESSEX INVESTMENT MANAGEMENT CO LLC 172,389$1,121,0000.18%
GSA CAPITAL PARTNERS LLP 384,976$2,502,0000.13%
View complete list of CORCEPT THERAPEUTICS INC shareholders